Table 1 Patient Demographics (n = 360).
Characteristic | All Patients | BCAP31 Expression | CRT Expression | GRP78 Expression | GRP94 Expression | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
High (n = 223) | Low (n = 137) | P | High (n = 164) | Low (n = 196) | P | High (n = 157) | Low (n = 203) | P | High (n = 231) | Low (n = 129) | P | ||
Age, years | 0.161 | 0.328 | 0.35 | 0.595 | |||||||||
Median | 58.5 | 59.6 | 56.7 | 59.3 | 57.9 | 59.2 | 58.0 | 58.8 | 58.4 | ||||
Range | 28–77 | 25–77 | 28–75 | 34–77 | 25–75 | 34–76 | 25–77 | 25–76 | 37–77 | ||||
Histological type | 0.992 | 0.348 | 0.811 | 0.975 | |||||||||
Squamous cell carcinoma | 239 | 148 | 91 | 109 | 130 | 104 | 135 | 157 | 82 | ||||
Adenocarcinoma | 85 | 53 | 32 | 35 | 50 | 40 | 45 | 56 | 29 | ||||
Large cell carcinoma | 36 | 22 | 14 | 20 | 16 | 17 | 19 | 23 | 13 | ||||
Clinico-pathologic stage | 0.373 | 0.114 | 0.007 | 0.773 | |||||||||
I (Ia + Ib) | 139 | 80 | 59 | 54 | 85 | 44 | 95 | 90 | 49 | ||||
II (IIa + IIb) | 131 | 86 | 45 | 67 | 64 | 66 | 65 | 89 | 42 | ||||
III (IIIa + IIIb) | 90 | 57 | 33 | 43 | 47 | 39 | 51 | 62 | 28 | ||||
Tumor size, cm | 0.725 | 0.052 | 0.185 | 0.071 | |||||||||
<3 | 35 | 20 | 15 | 10 | 25 | 19 | 16 | 21 | 14 | ||||
3–7 | 276 | 174 | 102 | 127 | 149 | 112 | 164 | 182 | 94 | ||||
>7 | 49 | 29 | 20 | 27 | 22 | 17 | 32 | 24 | 25 | ||||
Histological grade | 0.017 | 0.23 | 0.484 | 0.543 | |||||||||
High (grade 1) | 77 | 47 | 30 | 29 | 48 | 33 | 44 | 52 | 25 | ||||
Moderate (grade 2) | 164 | 91 | 73 | 73 | 91 | 71 | 93 | 99 | 65 | ||||
Poor (grade 3) | 83 | 64 | 20 | 42 | 41 | 44 | 39 | 57 | 26 | ||||
Unidentified | 36 | 22 | 14 | 20 | 16 | 17 | 19 | 23 | 13 | ||||
Nodal status | 0.588 | 0.848 | 0.25 | 0.212 | |||||||||
N0 | 198 | 121 | 77 | 94 | 104 | 79 | 119 | 120 | 78 | ||||
N1 | 97 | 64 | 33 | 43 | 54 | 45 | 52 | 64 | 33 | ||||
N2 | 65 | 38 | 27 | 29 | 36 | 33 | 32 | 47 | 18 | ||||